Middle East & Africa Infusion Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

The Middle East & Africa Infusion Devices Market size is expected to reach US$ 720.81 million by 2031 from US$ 457.09 million in 2023. The market is estimated to record a CAGR of 5.9% from 2023 to 2031. 

Executive Summary and Middle East & Africa Infusion Devices Market Analysis:

The Middle East and Africa infusion devices market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East and Africa. The region is expected to experience steady growth during the forecast period. The increasing prevalence of diabetes, cancer, and associated risk factors such as the aging population is expected to boost the demand for infusion pumps for their treatment. The UAE is estimated to be the fastest-growing country in the region due to the growing medical tourism in the country. 

Middle East & Africa Infusion Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Middle East & Africa Infusion Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Middle East & Africa infusion devices market analysis are product type, infusion pumps, infusion sets, application and end user.

• By product type, the Middle East & Africa infusion devices market is bifurcated into infusion pumps and infusion sets. The infusion pumps held a larger share of the market in 2023.
• In terms of infusion pumps, the market is segmented into volumetric pumps, syringe pumps, insulin pumps, patient control analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps. The volumetric pumps segment held the largest share of the market in 2023.
• By infusion sets, the Middle East & Africa infusion devices market is bifurcated into vented infusion sets and non-vented infusion sets. The vented infusion sets held a larger share of the market in 2023.
• By application, the Middle East & Africa infusion devices market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and other. The diabetes held the largest share of the market in 2023.
• By end user, the Middle East & Africa infusion devices market is segmented into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics held the largest share of the market in 2023.

Middle East & Africa Infusion Devices Market Outlook

The field of healthcare is experiencing significant technological advancements, with IV infusion systems leading the way in innovation. A few latest developments in IV infusion technology are smart pumps, wireless connectivity, electronic health record integration, and other features designed to improve operational efficiency. Smart Pump Integration: These devices are designed for precise and programmable fluid delivery, ensuring accurate dosing while ensuring patient safety. In addition to health benefits, smart pumps contribute to operational efficiency by automating and optimizing the infusion process. For example, in April 2024, Baxter announced the US FDA clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, advancing connected and intelligent infusion therapy. The Novum IQ Infusion Platform offers large volume and syringe infusion smart pumps on an integrated system with shared innovative digital health solutions to improve patient safety and efficiency for clinicians. Remote Monitoring: The integration of wireless connectivity in IV infusion systems can transform the handling of infusion therapies. This feature enables remote monitoring and management, allowing providers to supervise multiple infusion setups from a central location.

Remote monitoring technology also enhances the overall workflow within healthcare facilities and streamlines logistical aspects. Infuzamed provides a mobile, wearable infusion pump with advanced remote monitoring and control capabilities. The lightweight product eliminates the use of traditional cumbersome wires and poles. The device fits sleekly and comfortably on a patient's forearm and requires no additional attachments.

Electronic Health Records: Efficient data management is a fundamental aspect of modern healthcare, and advanced IV infusion systems integrate with electronic health records. The integration allows for streamlined documentation and administrative processes. Improved record-keeping and data accessibility contribute to enhanced operational efficiency, with positive implications for the entire healthcare system. WellSpan Health and CareFusion, a BD company, jointly announced the implementation of the Alaris System across all four WellSpan hospitals. WellSpan York Hospital is the first hospital to go live with the latest infusion device and bidirectional interoperability between the infusion device and the electronic health record.

Enhanced User Interface: User-friendly advancements and interfaces in human-machine interaction are essential to ensure the smooth operation of IV infusion systems. Also, intuitive designs contribute to the ease of use for healthcare professionals, potentially minimizing the likelihood of errors during administration. The focus is on enhancing user experience and operational proficiency without directly linking it to patient health outcomes. B. Braun offers a large-volume pump and a syringe pump with the same hardware architecture, user interface, and identical drug library and infusion management software.

Thus, the increasing technological advancements are expected to be a key trend in the Middle East & Africa infusion devices market.

Middle East & Africa Infusion Devices Market Country Insights

Based on country, the Middle East & Africa infusion devices market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest share in 2023.

The healthcare industry in Saudi Arabia is experiencing evolution due to advancements in technology and research and development related to international and local trends. The recent trend and industry dynamics require operators in the healthcare sector to make different decisions. There is a growth in the healthcare sector due to the demographic shift and increase in medical device reimbursement. The rise in the geriatric population boosts the demand for better healthcare plans and facilities. The geriatric population is at a high risk of chronic diseases such as diabetes and CVDs. According to IDF, in 2021, 4.27 million adults in Saudi Arabia had diabetes, with a prevalence of 17.7%. Therefore, the adoption of noninvasive infusion therapies with lesser adverse effects for the treatment of diabetes is expected to increase during the forecast period.

Middle East & Africa Infusion Devices Market Report Highlights

Middle East & Africa Infusion Devices Market Company Profiles

Some of the key players operating in the market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Infusion Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East & Africa Infusion Devices Market Country and Regional Insights